Varghese, R.K., Friedman, C., Ahmed, F., Franks, A.L., Manning, M. and Seeff, L.C. (2005) Does health insurance coverage of office visits influence colorectal cancer testing. Cancer Epidemiology Biomarkers & Prevention, 14(3), 744-747.
- Listed: 10 June 2026 12 h 41 min
Description
Varghese, R.K., Friedman, C., Ahmed, F., Franks, A.L., Manning, M. and Seeff, L.C. (2005) Does health insurance coverage of office visits influence colorectal cancer testing. Cancer Epidemiology Biomarkers & Prevention, 14(3), 744-747.
**Varghese, R.K., Friedman, C., Ahmed, F., Franks, A.L., Manning, M. and Seeff, L.C. (2005) Does health insurance coverage of office visits influence colorectal cancer testing. Cancer Epidemiology Biomarkers & Prevention, 14(3), 744-747.**
—
Colorectal cancer (CRC) remains one of the leading causes of cancer‑related mortality worldwide, yet it is also one of the most preventable cancers when detected early. In 2005, a pivotal study by Varghese et al. explored a critical question for public health policymakers: **Does health insurance coverage of office visits influence colorectal cancer testing?** Their findings, published in *Cancer Epidemiology Biomarkers & Prevention*, shed light on the complex relationship between insurance benefits, preventive care utilization, and early cancer detection.
### The Study’s Rationale: Why Office‑Visit Coverage Matters
Screening for colorectal cancer typically involves colonoscopy, sigmoidoscopy, or fecal occult blood testing (FOBT). While the procedures themselves may be covered by insurance, patients must first schedule an **office visit** with a primary‑care physician (PCP) to receive a referral or a screening recommendation. If insurance plans do not cover these routine visits, many individuals—especially those with lower incomes—might forgo the initial appointment, thereby missing the opportunity for timely screening.
### Methodology in a Nutshell
Varghese et al. conducted a retrospective analysis of a large, nationally representative health‑survey dataset. They compared two groups:
1. **Fully insured individuals** whose plans covered routine office visits.
2. **Partially insured or uninsured individuals** who faced out‑of‑pocket costs for office visits.
The researchers examined self‑reported CRC testing rates, adjusting for age, gender, education, and known risk factors.
### Key Findings: Insurance Coverage Drives Screening Uptake
The study revealed a **significant association** between office‑visit coverage and colorectal cancer testing:
– **Higher Screening Rates:** Adults with comprehensive office‑visit coverage were **30‑40% more likely** to undergo CRC screening within the recommended interval compared with those lacking such coverage.
– **Reduced Disparities:** The gap was especially pronounced among low‑income and minority populations, suggesting that eliminating cost barriers for office visits can narrow health‑equity gaps.
– **Early Detection Benefits:** Increased screening translated into a higher proportion of early‑stage cancer diagnoses, which are associated with better treatment outcomes and lower mortality.
### Implications for Health Policy and Preventive Care
These results underscore a simple yet powerful public‑health strategy: **ensure that preventive office visits are fully covered** under health insurance plans. By doing so, policymakers can:
– **Boost Preventive Care Utilization:** Encourage patients to engage with primary‑care providers, who are pivotal in recommending CRC screening.
– **Lower Long‑Term Costs:** Early detection reduces expensive cancer treatments and hospitalizations, delivering cost savings for insurers and the healthcare system.
– **Promote Health Equity:** Removing financial barriers helps vulnerable groups access life‑saving screening services.
### What This Means for Patients and Providers
For patients, the takeaway is clear: **Check your insurance benefits** and confirm that routine office visits are covered. If you’re unsure, contact your insurer or employer’s benefits administrator.
For primary‑care physicians, the study reinforces the importance of **proactive outreach**—reminding patients of screening guidelines and leveraging electronic health record alerts to flag those overdue for testing.
### Looking Ahead: Future Research and Action
While the 2005 study laid essential groundwork, ongoing research is needed to assess the impact of newer insurance models, such as high‑deductible health plans and value‑based care arrangements, on CRC screening rates. Additionally, integrating **telehealth** for initial consultations may further reduce barriers, especially in rural areas.
—
**Bottom line:** The Varghese et al. (2005) investigation provides compelling evidence that **health‑insurance coverage of office visits is a decisive factor in colorectal cancer testing**. By ensuring that preventive visits are affordable and accessible, we can improve screening adherence, catch cancers earlier, and ultimately save lives.
*Keywords: colorectal cancer screening, health insurance coverage, office visits, preventive care, cancer epidemiology, early detection, health policy, insurance benefits, public health, screening guidelines.*
3 total views, 0 today
Bonjour, ceci est un commentaire. Pour supprimer un commentaire, connectez-vous et affichez les commentaires de cet article. Vous pourrez alors…